A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection

Abstract A major challenge in the use of DNA vaccines is efficient DNA delivery in vivo. Establishing a safe and efficient electric transfer method is the key to developing rapid DNA vaccines against emerging infectious diseases. To overcome the complexity of designing new electric transfer machines...

Full description

Bibliographic Details
Main Authors: Tsai-Teng Tzeng, Kit Man Chai, Kuan-Yin Shen, Chia-Yi Yu, Shiu-Ju Yang, Wan-Chun Huang, Hung-Chun Liao, Fang-Feng Chiu, Horng-Yunn Dou, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-022-00482-0
_version_ 1797422237564796928
author Tsai-Teng Tzeng
Kit Man Chai
Kuan-Yin Shen
Chia-Yi Yu
Shiu-Ju Yang
Wan-Chun Huang
Hung-Chun Liao
Fang-Feng Chiu
Horng-Yunn Dou
Ching-Len Liao
Hsin-Wei Chen
Shih-Jen Liu
author_facet Tsai-Teng Tzeng
Kit Man Chai
Kuan-Yin Shen
Chia-Yi Yu
Shiu-Ju Yang
Wan-Chun Huang
Hung-Chun Liao
Fang-Feng Chiu
Horng-Yunn Dou
Ching-Len Liao
Hsin-Wei Chen
Shih-Jen Liu
author_sort Tsai-Teng Tzeng
collection DOAJ
description Abstract A major challenge in the use of DNA vaccines is efficient DNA delivery in vivo. Establishing a safe and efficient electric transfer method is the key to developing rapid DNA vaccines against emerging infectious diseases. To overcome the complexity of designing new electric transfer machines for DNA delivery, a clinically approved electric transfer machine could be considered as an alternative. Here, we report an electroacupuncture machine-based method for DNA vaccine delivery after intramuscular injection of the COVID-19 DNA vaccine. The S gene of SARS-CoV-2 in the pVAX1 plasmid (pSARS2-S) was used as an antigen in this study. We optimized the clinically used electroacupuncture machine settings for efficient induction of the neutralizing antibody titer after intramuscular injection of pSARS2-S in mice. We found that pSARS2-S immunization at 40 Vpp for 3–5 s could induce high neutralizing antibody titers and Th1-biased immune responses. IFN-γ/TNF-α-secreting CD4+ and CD8+ T cells were also observed in the DNA vaccination group but not in the recombinant protein vaccination group. T-cell epitope mapping shows that the major reactive epitopes were located in the N-terminal domain (a.a. 261–285) and receptor-binding domain (a.a. 352–363). Importantly, pSARS2-S immunization in hamsters could induce protective immunity against SARS-CoV-2 challenge in vivo. In the preclinical toxicology study, blood biochemistry, hematology, and DNA persistence analysis reveal that the DNA delivery method is safe. Furthermore, the raised antisera could also cross-neutralize different variants of concern. These findings suggest that DNA vaccination using an electroacupuncture machine is feasible for use in humans in the future.
first_indexed 2024-03-09T07:29:20Z
format Article
id doaj.art-7fd244ca7063404a8b9a951aeb84a487
institution Directory Open Access Journal
issn 2059-0105
language English
last_indexed 2024-03-09T07:29:20Z
publishDate 2022-06-01
publisher Nature Portfolio
record_format Article
series npj Vaccines
spelling doaj.art-7fd244ca7063404a8b9a951aeb84a4872023-12-03T06:28:29ZengNature Portfolionpj Vaccines2059-01052022-06-017111210.1038/s41541-022-00482-0A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infectionTsai-Teng Tzeng0Kit Man Chai1Kuan-Yin Shen2Chia-Yi Yu3Shiu-Ju Yang4Wan-Chun Huang5Hung-Chun Liao6Fang-Feng Chiu7Horng-Yunn Dou8Ching-Len Liao9Hsin-Wei Chen10Shih-Jen Liu11National Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesNational Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesNational Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesNational Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesNational Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesNational Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesNational Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesNational Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesNational Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesNational Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesNational Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesNational Institute of Infectious Diseases and Vaccinology, National Health Research InstitutesAbstract A major challenge in the use of DNA vaccines is efficient DNA delivery in vivo. Establishing a safe and efficient electric transfer method is the key to developing rapid DNA vaccines against emerging infectious diseases. To overcome the complexity of designing new electric transfer machines for DNA delivery, a clinically approved electric transfer machine could be considered as an alternative. Here, we report an electroacupuncture machine-based method for DNA vaccine delivery after intramuscular injection of the COVID-19 DNA vaccine. The S gene of SARS-CoV-2 in the pVAX1 plasmid (pSARS2-S) was used as an antigen in this study. We optimized the clinically used electroacupuncture machine settings for efficient induction of the neutralizing antibody titer after intramuscular injection of pSARS2-S in mice. We found that pSARS2-S immunization at 40 Vpp for 3–5 s could induce high neutralizing antibody titers and Th1-biased immune responses. IFN-γ/TNF-α-secreting CD4+ and CD8+ T cells were also observed in the DNA vaccination group but not in the recombinant protein vaccination group. T-cell epitope mapping shows that the major reactive epitopes were located in the N-terminal domain (a.a. 261–285) and receptor-binding domain (a.a. 352–363). Importantly, pSARS2-S immunization in hamsters could induce protective immunity against SARS-CoV-2 challenge in vivo. In the preclinical toxicology study, blood biochemistry, hematology, and DNA persistence analysis reveal that the DNA delivery method is safe. Furthermore, the raised antisera could also cross-neutralize different variants of concern. These findings suggest that DNA vaccination using an electroacupuncture machine is feasible for use in humans in the future.https://doi.org/10.1038/s41541-022-00482-0
spellingShingle Tsai-Teng Tzeng
Kit Man Chai
Kuan-Yin Shen
Chia-Yi Yu
Shiu-Ju Yang
Wan-Chun Huang
Hung-Chun Liao
Fang-Feng Chiu
Horng-Yunn Dou
Ching-Len Liao
Hsin-Wei Chen
Shih-Jen Liu
A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection
npj Vaccines
title A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection
title_full A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection
title_fullStr A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection
title_full_unstemmed A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection
title_short A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection
title_sort dna vaccine candidate delivered by an electroacupuncture machine provides protective immunity against sars cov 2 infection
url https://doi.org/10.1038/s41541-022-00482-0
work_keys_str_mv AT tsaitengtzeng adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT kitmanchai adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT kuanyinshen adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT chiayiyu adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT shiujuyang adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT wanchunhuang adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT hungchunliao adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT fangfengchiu adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT horngyunndou adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT chinglenliao adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT hsinweichen adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT shihjenliu adnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT tsaitengtzeng dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT kitmanchai dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT kuanyinshen dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT chiayiyu dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT shiujuyang dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT wanchunhuang dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT hungchunliao dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT fangfengchiu dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT horngyunndou dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT chinglenliao dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT hsinweichen dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection
AT shihjenliu dnavaccinecandidatedeliveredbyanelectroacupuncturemachineprovidesprotectiveimmunityagainstsarscov2infection